IRADIMED CORP - Common Stock (IRMD)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
7,049,520
Share change
+93,106
Total reported value
$421,491,084
Price per share
$59.79
Number of holders
160
Value change
+$6,336,537
Number of buys
76
Number of sells
71

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2025

As of 30 Jun 2025, IRADIMED CORP - Common Stock (IRMD) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,049,520 shares. The largest 10 holders included BlackRock, Inc., Nine Ten Capital Management LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Copeland Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, Ranger Investment Management, L.P., STATE STREET CORP, and ACADIAN ASSET MANAGEMENT LLC. This page lists 160 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.